Skip to main content
Premium Trial:

Request an Annual Quote

Genstruct Licenses Pathway Database from Jubilant Biosys

NEW YORK, April 27 (GenomeWeb News) - Jubilant Biosys, of Bangalore, India, said today that it has licensed its PathArt database of biochemical pathways to Genstruct for use in that company's drug discovery programs.


Genstruct will use the database to enhance its Molecular Epistemics platform for the discovery and definition of compound mechanism of action and biomarkers.


According to Jubilant, PathArt contains over 600 manually curated signaling, metabolic, and disease-specific pathways, including diseases such as cancer, arthritis, Alzheimer's, asthma, multiple sclerosis, Parkinson's, diabetes, and atherosclerosis.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.